Nivolumab Effective for Gastric and Lung Cancers but Not for Multiple Myeloma in a Multiple Primary Cancer Patient

The case of a 76-year-old man with multiple primary cancers that were treated with nivolumab is presented. Six years earlier, he was diagnosed with multiple myeloma (MM) and was treated with several chemotherapies. He was also diagnosed with gastric cancer with liver metastasis and primary lung canc...

Full description

Saved in:
Bibliographic Details
Published in:Case reports in hematology 2021-08, Vol.2021, p.1-4
Main Authors: Yasuda, Tsukasa, Hiraga, Junji, Narita, Michihiko, Tanikawa, Yoshimasa, Tsuzuki, Tomoyuki
Format: Article
Language:English
Subjects:
Antigens
Cancer
Cancer patients
Cancer therapies
Case Report
Case reports
Chemotherapy
Development and progression
Drug therapy
Gastric cancer
Hematology
Immunotherapy
Laboratories
Liver cancer
Lung cancer
Medical prognosis
Monoclonal antibodies
Multiple myeloma
Patients
Potassium
Proteins
Stomach cancer
Targeted cancer therapy
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The case of a 76-year-old man with multiple primary cancers that were treated with nivolumab is presented. Six years earlier, he was diagnosed with multiple myeloma (MM) and was treated with several chemotherapies. He was also diagnosed with gastric cancer with liver metastasis and primary lung cancer by upper gastrointestinal endoscopy and computed tomography (CT). Nivolumab treatment was given as third-line therapy, and it was effective for gastric and lung cancers. But MM worsened, and the patient died. There is no standard treatment for multiple primary cancers, and the development of effective treatments for multiple primary cancers is important.
ISSN:2090-6560
2090-6579
DOI:10.1155/2021/9965371